Pharmacokinetic of nevirapine in haemodialysis [9]

Nephrology Dialysis Transplantation

Volumn 16, Issue 1, 2001, Pages 192-193

  Izzedine, H ^a   Launay Vacher, V ^a   Aymard, G ^a   Legrand, M ^a   Deray, G ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CREATININE; DIDANOSINE; LIVER ENZYME; NEVIRAPINE; POLYSULFONE; RITONAVIR; SAQUINAVIR; STAVUDINE;

ABDOMINAL PAIN; ADULT; ANEMIA; AREA UNDER THE CURVE; BLOOD SAMPLING; CASE REPORT; CLEARANCE; DIALYSATE; DIARRHEA; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; MALE; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RASH; THROMBOCYTOPENIA; TIME; VIRUS LOAD;

EID: 0035160036     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.1.192     Document Type: Letter

References (4)

1. Pharmacokinetics and potential interactions amongst anti-retroviral agents used to treat patients with HIV infection
2. Disposition and biotransformation of the antiretroviral drug nevirapine in humans
3. Existence of a flip-flop kinetic model for zidovudine (AZT) after oral administration
4. Population pharmaco-kinetics of nevirapine (NVP), zidovadine (ZDV) and didanosine (ddI) in human immunodeficiency virus-infected patients